HOMA2-B as a Single Time-Point Measurement to Stratify Risk of T1D Development
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Diabetologia
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
HOMA2-B enhances assessment of type 1 diabetes risk among TrialNet Pathway to Prevention participants
Diabetologia 2022 Jan 01;65(1)88-100, JL Felton, D Cuthbertson, M Warnock, K Lohano, F Meah, JM Wentworth, J Sosenko, C Evans-MolinaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.